Home › Free Stock Grades › IART
Integra LifeSciences Holdings Corporation (IART) Stock Grade
IART · Healthcare
C
Market Cap
$1.3B
P/E Ratio
—
Revenue Growth (YoY)
+1.5%
Net Margin
-31.6%
Return on Equity
—
Dividend Yield
None
About Integra LifeSciences Holdings Corporation's fundamentals
Integra LifeSciences is a medical devices company with a market capitalization of $1.3 billion that reported minimal revenue growth of 1.5% year-over-year. The company is currently unprofitable, posting a net margin of -31.6% and reporting a net loss in its latest annual statement, which means it is spending more than it generates in revenue. The company does not pay a dividend, and traditional valuation metrics like P/E ratio and return on equity are not available due to the negative earnings.